CALL - SPRINTER OPEN END - ROCHE GS Share Price

Certificat

DE000VN5YTC2

Real-time Bid/Ask 06:32:04 29/04/2024 pm IST
4.73 EUR / 4.74 EUR +8.35% Intraday chart for CALL - SPRINTER OPEN END - ROCHE GS
Current month-15.15%
1 month-12.60%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
29/24/29 4.56 +4.35% 0
26/24/26 4.37 -4.38% 0
25/24/25 4.57 -15.37% 0
24/24/24 5.4 +7.57% 0
23/24/23 5.02 +6.58% 0

Delayed Quote Börse Stuttgart

Last update April 29, 2024 at 12:11 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VN5YTC
ISINDE000VN5YTC2
Date issued 02/12/2016
Strike 177.2 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 3.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 22.15
Lowest since issue 2.65
Spread 0.01
Spread %0.21%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
221 CHF
Average target price
279.4 CHF
Spread / Average Target
+26.42%
Consensus